Accelmed Partners II and Lauxera Capital Invest in Veranex
November 14, 2022
Veranex has received strategic growth investments from Accelmed Partners II and Lauxera Capital Partners, joining existing investor Summit Partners, which retains majority ownership. The investments — terms undisclosed — will support Veranex’s continued global expansion and development of its integrated, tech‑enabled medical technology product development services; Uri Geiger (Accelmed) and Samuel Levy (Lauxera) joined Veranex’s board.
- Buyers
- Accelmed Partners II, Lauxera Capital Partners, Summit Partners
- Targets
- Veranex
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Veranex (backed by Summit Partners) Forms Platform and Acquires Ximedica, Quartesian, and Boston Healthcare Associates
June 16, 2021
Healthcare Services
Veranex, formed in partnership with growth investor Summit Partners, launched a concept-to-commercialization medtech services platform and acquired three complementary companies: Ximedica, Quartesian, and Boston Healthcare Associates. The combined business brings design and engineering, clinical data, regulatory, and market-access/HEOR capabilities together to create an integrated, global medtech service provider.
-
Veranex Acquires Medidee to Expand European MedTech Capabilities
September 20, 2022
Healthcare Services
Veranex has acquired Medidee, a Lausanne-based MedTech regulatory and clinical consultancy, expanding Veranex's footprint and capabilities across Europe, India and APAC. The deal strengthens Veranex’s regulatory affairs, clinical development, and quality assurance services for medical device and in vitro diagnostic clients; financial terms were not disclosed.
-
Veranex Acquires Devicia, Clarvin and Affiliate Consultancies
October 11, 2022
Healthcare Services
Veranex, a global tech-enabled medtech service provider, acquired an ecosystem of Swedish medical device and IVD consultancies led by Devicia and Clarvin (including affiliates Kickfile, Lea Reg, and Limulus Bio). The add-on expands Veranex's regulatory, clinical, quality assurance, and biocompatibility capabilities and strengthens its European and UK presence to support MDR/IVDR strategies and local representation.
-
Veranex Acquires Fusion Biotec
December 13, 2022
Medical Devices
Veranex has acquired Fusion Biotec, a Southern California design and engineering firm specializing in complex electro-mechanical diagnostic instrumentation and medical devices. The acquisition brings Fusion's 15,000-square-foot facility and 45+ engineering staff into Veranex's Product Design & Engineering capabilities, expanding Veranex's diagnostic/IVD development, software/firmware reuse and Southern California footprint; financial terms were not disclosed.
-
Concord Health Partners Leads Growth Financing in Accelus
May 29, 2025
Medical Devices
Accelus, a Palm Beach Gardens-based medical technology company specializing in expandable spinal implant technologies, closed a new equity financing round led by healthcare-focused investment firm Concord Health Partners. The capital will support Accelus's U.S. commercial expansion and further development of its spinal implant product pipeline.
-
Vestar Capital Partners Invests Growth Capital in Nox Health
November 30, 2022
Healthcare Services
Vestar Capital Partners has made a strategic growth investment in Nox Health to accelerate development of the company's sleep diagnostic technology and expand adoption of its value-based sleep management solutions among employers and health plans. Financial terms were not disclosed; the investment will support product and service development and broader market expansion.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.